Interactions/NNS
of/IN
a/DT
transcriptional/JJ
activator/NN
in/IN
the/DT
env/NN
gene/NN
of/IN
the/DT
mouse/NN
mammary/JJ
tumor/NN
virus/NN
with/IN
activation-dependent/JJ
,/,
T/NN
cell-specific/JJ
transacting/VBG
factors/NNS
./.

The/DT
mouse/NN
mammary/JJ
tumor/NN
virus/NN
env/NN
gene/NN
contains/VBZ
a/DT
transcriptional/JJ
activator/NN
(/(
META/NN
)/)
that/WDT
can/MD
control/VB
transcription/NN
of/IN
the/DT
adjacent/JJ
long/JJ
terminal/JJ
repeat/NN
region/NN
./.
=====
Transcriptional/JJ
control/NN
by/IN
META/NN
parallels/VBZ
that/DT
of/IN
several/JJ
lymphokine/NN
genes/NNS
,/,
being/VBG
specific/JJ
to/TO
T/NN
cells/NNS
,/,
dependent/JJ
on/IN
their/PRP$
activation/NN
,/,
and/CC
inhibited/VBN
by/IN
the/DT
immunosuppressive/JJ
drug/NN
cyclosporine/NN
(/(
CsA/NN
)/)
./.
=====
DNase/NN
I/CD
footprinting/NN
indicated/VBD
that/IN
nuclear/JJ
factors/NNS
from/IN
activated/VBN
T/NN
lymphocytes/NNS
bound/VBD
a/DT
promoter-proximal/JJ
site/NN
,/,
META(P)/NN
,/,
and/CC
a/DT
promoter-distal/JJ
site/NN
,/,
META(D+)/NN
,/,
within/IN
the/DT
400-base/JJ
pair/NN
META/NN
region/NN
./.
=====
Nuclear/JJ
factors/NNS
from/IN
unstimulated/JJ
,/,
but/CC
not/RB
from/IN
activated/VBN
cells/NNS
,/,
bound/VBD
a/DT
site/NN
,/,
META(D-)/NN
,/,
adjacent/JJ
to/TO
META(D+)/NN
./.
=====
META(D+)/NN
directed/VBD
transcription/NN
of/IN
a/DT
linked/VBN
luciferase/NN
gene/NN
,/,
and/CC
gel/NN
shift/NN
analysis/NN
revealed/VBD
binding/NN
of/IN
inducible/JJ
,/,
CsA-sensitive/JJ
T/NN
cell/NN
factors/NNS
,/,
in/IN
parallel/NN
with/IN
transfection/NN
results/NNS
./.
=====
Authentic/JJ
NFAT/NN
and/CC
NF-kappaB/NN
targets/NNS
did/VBD
not/RB
compete/VB
for/IN
the/DT
META(D+)/NN
binding/NN
factor/NN
(/(
s/NNS
)/)
./.
=====
The/DT
SV40/NN
core/NN
sequence/NN
competed/VBD
for/IN
META(D+)/NN
binding/NN
factors/NNS
,/,
but/CC
META(D+)/NN
failed/VBD
to/TO
compete/VB
for/IN
the/DT
complexes/NNS
obtained/VBN
with/IN
the/DT
SV40/NN
probe/NN
./.
=====
Our/PRP$
results/NNS
,/,
taken/VBN
together/RB
,/,
indicate/VBP
that/IN
META(D+)/NN
is/VBZ
a/DT
novel/JJ
transcriptional/JJ
enhancer/NN
element/NN
that/WDT
is/VBZ
similar/JJ
in/IN
its/PRP$
cell-type/JJ
specificity/NN
,/,
activation/NN
dependence/NN
,/,
and/CC
CsA/NN
sensitivity/NN
to/TO
the/DT
NFAT/NN
element/NN
./.
=====
It/PRP
may/MD
be/VB
relevant/JJ
to/TO
the/DT
role/NN
of/IN
MMTV/NN
in/IN
expression/NN
of/IN
Mls/NN
antigens/NNS
or/CC
the/DT
induction/NN
of/IN
T/NN
cell/NN
lymphomas/NNS
./.